These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here? Fung EN; Jemal M; Aubry AF Bioanalysis; 2013 May; 5(10):1277-84. PubMed ID: 23721448 [TBL] [Abstract][Full Text] [Related]
43. Quantitation of small molecules using high-resolution accurate mass spectrometers - a different approach for analysis of biological samples. Zhang NR; Yu S; Tiller P; Yeh S; Mahan E; Emary WB Rapid Commun Mass Spectrom; 2009 Apr; 23(7):1085-94. PubMed ID: 19263405 [TBL] [Abstract][Full Text] [Related]
44. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. Sajic T; Liu Y; Aebersold R Proteomics Clin Appl; 2015 Apr; 9(3-4):307-21. PubMed ID: 25504613 [TBL] [Abstract][Full Text] [Related]
45. The benefit of combining nLC-MALDI-Orbitrap MS data with nLC-MALDI-TOF/TOF data for proteomic analyses employing elastase. Rietschel B; Baeumlisberger D; Arrey TN; Bornemann S; Rohmer M; Schuerken M; Karas M; Meyer B J Proteome Res; 2009 Nov; 8(11):5317-24. PubMed ID: 19725589 [TBL] [Abstract][Full Text] [Related]
46. Quadrupole time-of-flight versus triple-quadrupole mass spectrometry for the determination of non-steroidal antiinflammatory drugs in surface water by liquid chromatography/tandem mass spectrometry. Marchese S; Gentili A; Perret D; Ascenzo GD; Pastori F Rapid Commun Mass Spectrom; 2003; 17(9):879-86. PubMed ID: 12717759 [TBL] [Abstract][Full Text] [Related]
47. Application of high-resolution MS for development of peptide and large-molecule drug candidates. Kellie JF; Kehler JR; Szapacs ME Bioanalysis; 2016 Feb; 8(3):169-77. PubMed ID: 26795399 [TBL] [Abstract][Full Text] [Related]
48. Evolution of Orbitrap Mass Spectrometry Instrumentation. Eliuk S; Makarov A Annu Rev Anal Chem (Palo Alto Calif); 2015; 8():61-80. PubMed ID: 26161972 [TBL] [Abstract][Full Text] [Related]
49. Using high-resolution quadrupole TOF technology in DMPK analyses. Campbell JL; Le Blanc JC Bioanalysis; 2012 Mar; 4(5):487-500. PubMed ID: 22409548 [TBL] [Abstract][Full Text] [Related]
50. Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS. Plumb RS; Fujimoto G; Mather J; Potts WB; Rainville PD; Ellor NJ; Evans C; Kehler JR; Szapacs ME Bioanalysis; 2012 Mar; 4(5):605-15. PubMed ID: 22409557 [TBL] [Abstract][Full Text] [Related]
51. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Xia YQ; Lau J; Olah T; Jemal M Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2863-78. PubMed ID: 21913265 [TBL] [Abstract][Full Text] [Related]
52. Parallelized Acquisition of Orbitrap and Astral Analyzers Enables High-Throughput Quantitative Analysis. Stewart HI; Grinfeld D; Giannakopulos A; Petzoldt J; Shanley T; Garland M; Denisov E; Peterson AC; Damoc E; Zeller M; Arrey TN; Pashkova A; Renuse S; Hakimi A; Kühn A; Biel M; Kreutzmann A; Hagedorn B; Colonius I; Schütz A; Stefes A; Dwivedi A; Mourad D; Hoek M; Reitemeier B; Cochems P; Kholomeev A; Ostermann R; Quiring G; Ochmann M; Möhring S; Wagner A; Petker A; Kanngiesser S; Wiedemeyer M; Balschun W; Hermanson D; Zabrouskov V; Makarov AA; Hock C Anal Chem; 2023 Oct; 95(42):15656-15664. PubMed ID: 37815927 [TBL] [Abstract][Full Text] [Related]
53. Application of ion trap technology to liquid chromatography/mass spectrometry quantitation of large peptides. Shipkova P; Drexler DM; Langish R; Smalley J; Salyan ME; Sanders M Rapid Commun Mass Spectrom; 2008 May; 22(9):1359-66. PubMed ID: 18381620 [TBL] [Abstract][Full Text] [Related]
54. How specific is my SRM?: The issue of precursor and product ion redundancy. Sherman J; McKay MJ; Ashman K; Molloy MP Proteomics; 2009 Mar; 9(5):1120-3. PubMed ID: 19253278 [TBL] [Abstract][Full Text] [Related]
55. Targeted proteomics: a bridge between discovery and validation. Harlan R; Zhang H Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939 [TBL] [Abstract][Full Text] [Related]
56. The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases. Gianazza E; Tremoli E; Banfi C Expert Rev Proteomics; 2014 Dec; 11(6):771-88. PubMed ID: 25400095 [TBL] [Abstract][Full Text] [Related]
57. Development of a simple and reliable accurate mass liquid chromatography/electrospray ionization mass spectrometry method for high-resolution accurate mass determinations of new drug entities on a triple quadrupole mass spectrometer. Pucci V; Bonelli F Rapid Commun Mass Spectrom; 2007; 21(18):3051-9. PubMed ID: 17705256 [TBL] [Abstract][Full Text] [Related]
58. The assessment of selectivity in different Quadrupole-Orbitrap mass spectrometry acquisition modes. Berendsen BJ; Wegh RS; Meijer T; Nielen MW J Am Soc Mass Spectrom; 2015 Feb; 26(2):337-46. PubMed ID: 25391727 [TBL] [Abstract][Full Text] [Related]
59. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform. Oh JH; Pan S; Zhang J; Gao J Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694 [TBL] [Abstract][Full Text] [Related]